Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction

被引:1
|
作者
Rades, Dirk [1 ,7 ]
Kopelke, Svenja [1 ,2 ]
Schild, Steven E. [3 ]
Tvilsted, Soeren [4 ]
Kjaer, Troels W. [5 ]
Bartscht, Tobias [2 ,6 ]
机构
[1] Univ Lubeck, Dept Radiat Oncol, Lubeck, Germany
[2] Univ Lubeck, Dept Hematol & Oncol, Lubeck, Germany
[3] Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA
[4] Zealand Univ Hosp, Res Dept, Koge, Denmark
[5] Zealand Univ Hosp, Neurol Dept, Roskilde, Denmark
[6] Helios Hosp, Dept Hematol Oncol & Stem Cell Transplantat, Schwerin, Germany
[7] Univ Lubeck, Dept Radiat Oncol, Ratzeburger Allee 160, D-23562 Lubeck, Germany
关键词
Esophageal cancer; adenocarcinoma of the esophagogastric junction; radio-chemotherapy; sleep problems; prevalence; risk factors; ESOPHAGECTOMY; DOCETAXEL; CISPLATIN;
D O I
10.21873/anticanres.15955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Many patients with locally advanced cancer of the esophagus or esophagogastric junction receive definitive or neoadjuvant radiochemotherapy. Patient anticipation of this treatment can cause or aggravate distress and sleep disorders. This study aimed to identify the prevalence of sleep disorders and risk factors. Patients and Methods: Thirty-eight patients assigned to radio-chemotherapy were retrospectively evaluated for pre-treatment sleep disorders. Investigated characteristics included age; sex; performance score; comorbidity index; emotional, physical or practical problems; tumor site; histology and grading; tumor stage; planned treatment; and relation to 2019 Coronavirus pandemic. Results: Sleep problems were reported by 15 patients (39.5%). Significant associations were found for higher distress scores (p=0.016) and greater numbers of emotional problems (p<0.0001). A trend was observed for greater numbers of physical problems (p=0.176). Conclusion: The prevalence of sleep problems
引用
收藏
页码:4529 / 4533
页数:5
相关论文
共 50 条
  • [41] CLASSIFICATION OF GOOD AND BAD RESPONDERS IN LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT RADIO-CHEMOTHERAPY USING RADIOMICS SIGNATURE
    Buzea, Calin Gh
    Mirestean, Camil C.
    Agop, Maricel
    Paun, Viorel Puiu
    Iancu, Dragos T.
    UNIVERSITY POLITEHNICA OF BUCHAREST SCIENTIFIC BULLETIN-SERIES A-APPLIED MATHEMATICS AND PHYSICS, 2019, 81 (02): : 265 - 278
  • [42] Classification of good and bad responders in locally advanced rectal cancer after neoadjuvant radio-chemotherapy using radiomics signature
    Buzea, Calin Gh.
    Mirestean, Camil C.
    Agop, Maricel
    Paun, Viorel Puiu
    Iancu, Dragos T.
    UPB Scientific Bulletin, Series A: Applied Mathematics and Physics, 2019, 81 (02): : 265 - 278
  • [43] ENDOSCOPIC ULTRASONOGRAPHY IN THE QUANTITATIVE ASSESSMENT OF RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH ADENOCARCINOMA OF THE ESOPHAGUS AND ESOPHAGOGASTRIC JUNCTION
    ROUBEIN, LD
    DUBROW, R
    DAVID, C
    LYNCH, P
    FORNAGE, B
    AJANI, J
    ROTH, J
    LEVIN, B
    ENDOSCOPY, 1993, 25 (09) : 587 - 591
  • [44] PHARMACOGENETICS & TREATMENT OUTCOME IN CANCER PATIENTS RECEIVING RADIO-CHEMOTHERAPY
    Yadav, S. S.
    Chauhan, V.
    Parmar, D.
    ANNALS OF ONCOLOGY, 2015, 26
  • [45] Comparison of preoperative concurrent chemoradiotherapy with chemotherapy alone in patients with locally advanced siewert II and III adenocarcinoma of the esophagogastric junction
    Ge, Xueke
    Zhao, Qun
    Song, Yuzhi
    Li, Jing
    Liu, Ming
    Bai, Wenwen
    Qiao, Xueying
    EJSO, 2018, 44 (04): : 502 - 508
  • [46] Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy
    Bartl, Thomas
    Dorittke, Tim
    Ciocsirescu, Cristina-Ioana
    Knoth, Johannes
    Schmid, Maximilian
    Grimm, Christoph
    Sturdza, Alina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A123 - A124
  • [47] Predicting survival and local control after radio-chemotherapy in locally advanced head and neck cancer by means of CT based radiomics
    Luca, Cozzi
    Cozzi, L.
    Fogliata, A.
    Franzese, C.
    Scorsetti, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1133 - 1133
  • [48] Metabolic Monitoring by 18F-FDG PET during Radio-chemotherapy for Locally Advanced Cervical Cancer: Predicting Outcome
    Leseur, J.
    Devillers, A.
    Arango, J. Ospina
    Williaume, D.
    Lecouillard, I.
    Leveque, J.
    Louvel, G.
    Gnep, K.
    Garin, E.
    De Crevoisier, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S47 - S48
  • [49] EARLY CLINICAL OUTCOMES OF HELICAL TOMOTHERAPY WITH SIMULTANEOUS INTEGRATED BOOST IN THE CONCURRENT RADIO-CHEMOTHERAPY OF LOCALLY ADVANCED HEAD AND NECK CANCER
    Usychkin, S.
    Schiappacasse, L.
    Matute, R.
    Schnitman, F.
    Sevillano, D.
    Minguez, C.
    Cendales, R.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S37 - S37
  • [50] Randomized clinical trial on accelerated preoperative hyperfractionated radiotherapy versus preoperative hyperfractionated radio-chemotherapy in locally advanced rectal cancer
    Idasiak, Adam
    Ziolkowska, Barbara
    Rajczykowski, Marcin
    Galwas, Katarzyna
    Debosz-Suwinska, Iwona
    Zeman, Marcin
    Mrochem-Kwarciak, Jolanta
    Suwinski, Rafal
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1163): : 1879 - 1889